loading
Schlusskurs vom Vortag:
$3.57
Offen:
$3.57
24-Stunden-Volumen:
153.02K
Relative Volume:
1.52
Marktkapitalisierung:
$176.68M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.90M
KGV:
-7.0943
EPS:
-0.53
Netto-Cashflow:
$-19.80M
1W Leistung:
-1.31%
1M Leistung:
-8.74%
6M Leistung:
-32.37%
1J Leistung:
+30.10%
1-Tages-Spanne:
Value
$3.55
$3.81
1-Wochen-Bereich:
Value
$3.475
$3.99
52-Wochen-Spanne:
Value
$2.8302
$6.8184

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Name
Firmenname
Diamedica Therapeutics Inc
Name
Telefon
(763) 496-5454
Name
Adresse
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Name
Mitarbeiter
28
Name
Twitter
@diamedica
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
DMAC's Discussions on Twitter

Vergleichen Sie DMAC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DMAC
Diamedica Therapeutics Inc
3.76 176.68M 0 -19.90M -19.80M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-07 Eingeleitet H.C. Wainwright Buy
2024-04-24 Fortgesetzt Craig Hallum Buy
2023-06-22 Hochstufung Oppenheimer Perform → Outperform
2021-04-09 Eingeleitet Oppenheimer Outperform
2021-02-17 Eingeleitet ROTH Capital Buy
2020-10-30 Eingeleitet Guggenheim Buy
2020-07-08 Eingeleitet Maxim Group Buy
2019-04-30 Eingeleitet Dougherty & Company Buy
2019-03-05 Eingeleitet Lake Street Buy
Alle ansehen

Diamedica Therapeutics Inc Aktie (DMAC) Neueste Nachrichten

pulisher
Jun 14, 2025

DiaMedica Therapeutics Insiders Up US$4.1m On US$9.00m Investment - simplywall.st

Jun 14, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Increases Holdings in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

42,212 Shares in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Purchased by Jane Street Group LLC - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Can DiaMedica Deliver A Breakthrough In Preeclampsia Treatment? - RTTNews

Jun 04, 2025
pulisher
Jun 04, 2025

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Increases By 38.3% - Defense World

Jun 04, 2025
pulisher
May 30, 2025

Lake Street Keeps Their Buy Rating on Diamedica Therapeutics (DMAC) - The Globe and Mail

May 30, 2025
pulisher
May 30, 2025

Northern Trust Corp Has $978,000 Holdings in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

May 30, 2025
pulisher
May 30, 2025

DMAC: HC Wainwright & Co. Reiterates Buy Rating with $10 Price T - GuruFocus

May 30, 2025
pulisher
May 30, 2025

DiaMedica Therapeutics’ (DMAC) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

May 30, 2025
pulisher
May 29, 2025

H.C. Wainwright holds DiaMedica stock Buy rating, $10 target - Investing.com

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright holds DiaMedica stock Buy rating, $10 target By Investing.com - Investing.com India

May 29, 2025
pulisher
May 28, 2025

Transcript : DiaMedica Therapeutics Inc.Special Call - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

With 39% ownership, DiaMedica Therapeutics Inc. (NASDAQ:DMAC) insiders have a lot riding on the company's future - Yahoo Finance

May 28, 2025
pulisher
May 22, 2025

DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025 - BioSpace

May 22, 2025
pulisher
May 22, 2025

DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025 | DMAC Stock News - GuruFocus

May 22, 2025
pulisher
May 20, 2025

14,581 Shares in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Purchased by Balyasny Asset Management L.P. - Defense World

May 20, 2025
pulisher
May 19, 2025

DiaMedica Therapeutics Announces Key Opinion Leader Webinar on D - GuruFocus

May 19, 2025
pulisher
May 19, 2025

DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia - Business Wire

May 19, 2025
pulisher
May 19, 2025

Research Analysts Offer Predictions for DMAC FY2025 Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Equities Analysts Offer Predictions for DMAC FY2029 Earnings - Defense World

May 18, 2025
pulisher
May 17, 2025

DiaMedica targets preeclampsia Phase 2 dose selection and ReMEDy2 interim analysis in H1 2026 as enrollment momentum builds - MSN

May 17, 2025
pulisher
May 16, 2025

Analysts Offer Insights on Healthcare Companies: Organon (OGN), Diamedica Therapeutics (DMAC) and Nkarta (NKTX) - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

Craig-Hallum Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC) - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

DiaMedica Therapeutics reports annual meeting results By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 15, 2025

DiaMedica Therapeutics reports annual meeting results - Investing.com

May 15, 2025
pulisher
May 15, 2025

DiaMedica Elects Directors at Annual Meeting - TipRanks

May 15, 2025
pulisher
May 15, 2025

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

DiaMedica Therapeutics Inc (DMAC) Q1 2025 Earnings Call Highlights: Strong Financial Position ... - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

DiaMedica Therapeutics Inc (DMAC) Q1 2025 Earnings Call Highligh - GuruFocus

May 15, 2025
pulisher
May 15, 2025

DiaMedica Therapeutics Reports Q1 2025 Financials and Trial Progress - TipRanks

May 15, 2025
pulisher
May 14, 2025

DiaMedica Therapeutics Announces Poster Presentation at European - GuruFocus

May 14, 2025
pulisher
May 14, 2025

DiaMedica Therapeutics Announces Poster Presentation At European Stroke Organisation ConferenceESOC 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference -- ESOC 2025 | DMAC Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025 - Business Wire

May 14, 2025
pulisher
May 14, 2025

DiaMedica (DMAC) Awaits Key Phase 2 Study Results for Preeclamps - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Earnings call transcript: DiaMedica Therapeutics Q1 2025 earnings beat expectations By Investing.com - Investing.com India

May 14, 2025
pulisher
May 14, 2025

Transcript : DiaMedica Therapeutics Inc., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Earnings call transcript: DiaMedica Therapeutics Q1 2025 earnings beat expectations - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

Barclays PLC Takes Position in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Makes New Investment in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

May 14, 2025
pulisher
May 13, 2025

DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights - BioSpace

May 13, 2025
pulisher
May 13, 2025

DiaMedica Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

DiaMedica Therapeutics Reports Q1 2025 Financial Results and Clinical Progress - TipRanks

May 13, 2025
pulisher
May 13, 2025

DiaMedica Therapeutics Reports First Quarter 2025 Financial Resu - GuruFocus

May 13, 2025
pulisher
May 13, 2025

DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights | DMAC Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

DiaMedica Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat

May 13, 2025
pulisher
May 10, 2025

Susquehanna International Group LLP Grows Holdings in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - The AM Reporter

May 10, 2025
pulisher
May 08, 2025

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May - BioSpace

May 08, 2025
pulisher
May 08, 2025

How To Trade (DMAC) - news.stocktradersdaily.com

May 08, 2025

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Diamedica Therapeutics Inc-Aktie (DMAC) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Giuffre Randall Michael
Director
Feb 13 '25
Option Exercise
2.56
17,000
43,570
392,412
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):